Suppr超能文献

在政府资助或运营的机构中,严重精神疾病患者的后续精神科护理和再入院风险。

Follow-up Psychiatric Care and Risk of Readmission in Patients with Serious Mental Illness in State Funded or Operated Facilities.

机构信息

Eagle Technologies, Inc, Arlington, VA, USA.

出版信息

Psychiatr Q. 2022 Jun;93(2):499-511. doi: 10.1007/s11126-021-09957-0. Epub 2021 Oct 25.

Abstract

Receipt of outpatient treatment within 30 days of discharge from psychiatric hospitalization is an established quality indicator; however, there is scant, mixed evidence as to whether it reduces the risk of readmission. We evaluated this question in patients hospitalized for schizophrenic, bipolar or depressive disorders using the Mental Health Treatment Episode Data Set (MH-TEDS), comprising patients in state-funded or -operated facilities and programs. We performed a 6-month, retrospective longitudinal cohort study including 44,761 patients with schizophrenic disorders, 45,413 patients with bipolar disorders, and 74,995 patients with depressive disorders with an index hospitalization between 2014 and 2018, stratified by whether they had at least one outpatient treatment admission in the first 30 days post-discharge. We used multivariable logistic regression to assess risk of readmission during days 31-180. We found that less than 10 percent of patients in the three cohorts received the recommended follow-up outpatient care. Furthermore, we found that schizophrenic and bipolar patients who did receive such care were no less likely to be readmitted than those not receiving such care (AOR = 0.96, 95% CI 0.87-1.06; AOR 1.06, 955 CI 0.98-1.14), and patients with depressive disorders receiving such care were more likely to be readmitted (AOR = 1.14, 95% CI 1.07-1.22). Thus, few patients received follow-up outpatient care within 30 days of discharge. When it occurred, such outpatient care was either not linked to reduced readmissions or was associated with increased readmissions. These findings suggest the need for more effective care processes in state-funded or -operated facilities.

摘要

在精神科住院出院后 30 天内接受门诊治疗是既定的质量指标;然而,关于它是否降低再入院风险的证据很少且相互矛盾。我们使用心理健康治疗期数据(Mental Health Treatment Episode Data Set,MH-TEDS)评估了在州立或运营的设施和项目中住院的精神分裂症、双相情感障碍或抑郁症患者的这一问题。我们进行了一项为期 6 个月的回顾性纵向队列研究,纳入了 2014 年至 2018 年期间患有精神分裂症的 44761 名患者、患有双相情感障碍的 45413 名患者和患有抑郁症的 74995 名患者,他们的索引住院发生在 30 天内出院后的 31-180 天。我们使用多变量逻辑回归来评估再入院风险。我们发现,三个队列中不到 10%的患者接受了推荐的门诊随访。此外,我们发现接受这种护理的精神分裂症和双相情感障碍患者再入院的可能性并不低于未接受这种护理的患者(AOR=0.96,95%CI 0.87-1.06;AOR 1.06,955 CI 0.98-1.14),而接受这种护理的抑郁症患者更有可能再入院(AOR=1.14,95%CI 1.07-1.22)。因此,很少有患者在出院后 30 天内接受门诊随访。当发生这种情况时,这种门诊护理要么与减少再入院无关,要么与增加再入院有关。这些发现表明,州立或运营的设施需要更有效的护理流程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb50/9046324/69cd0d74774a/11126_2021_9957_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验